Table 1.
Main characters of retrospective cohort studies included in this meta-analysis.
| Number |
Age |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| First Author | Year | country | Race | Type | Total | 3cyc | 4cyc | NAC regimen | 3cyc | 4cyc | Stage |
| Ahmet Murat Aydin | 2022 | America | Mixed | Retrospective single center | 166 | 107 | 59 | GC (166) | 66 (60, 73) | 65 (59,71) | Stage I/II (118[71.1%]) Stage III (32[19.3%]) Stage IV (16[9.6%]) |
| David D’Andrea | 2022 | Austria | Caucasian | Retrospective multicenter | 828 | 384 | 444 | GC (659[79.6%]); MVAC (78[9.4%]); DD-MVAC (82[9.9%]); Other (9[1.1%]) |
65 (58, 71) | 63 (57, 70) | T2 (553[66.8%]) T3 (204[24.6%]) T4 (71[8.6%]) |
| Hiten D. Patel | 2022 | America | Mixed | Retrospective multicenter | 271 | 114 | 157 | GC (231[85.2%]); DD-MVAC (37[13.7%]); Other (3[1.1%]) |
64 (56, 70) | 67 (60, 72) | T2 (227[83.8%]) T3 (38[14.0%]) T4 (6[2.2%]) |
| Karin Holmsten | 2022 | Sweden | Caucasian | Retrospective multicenter | 706 | 251 | 455 | GC (706) | 67 (44, 80) | 65 (34, 79) | T2 (347[49.1%]) T3 (165[23.4%]) T4 (35[5.0%]) Not assessable (159[22.5%]) |
| Matteo Ferro | 2021 | Italy | Caucasian | Retrospective multicenter | 219 | 160 | 59 | GC (219) | 66 (59, 72) | 66 (60, 74) | ≤T2 (132[60.3%]) ≥T3 (87[39.8%]) |